(Q39220066)

10 September 2017

title

Investigating the role of nucleoside transporters in the resistance of colorectal cancer to 5-fluorouracil therapy (English)

1 reference

10 September 2017

1 reference

1 reference

1 reference

Lee Cheng Phua

1

1 reference

10 September 2017

Mainak Mal

2

1 reference

10 September 2017

Poh Koon Koh

3

1 reference

10 September 2017

Peh Yean Cheah

4

1 reference

10 September 2017

Eric Chun Yong Chan

5

1 reference

10 September 2017

Han Kiat Ho

6

1 reference

10 September 2017

language of work or name

English

0 references

publication date

28 December 2012

1 reference

Cancer Chemotherapy and Pharmacology

10 September 2017

published in

1 reference

10 September 2017

volume

71

1 reference

10 September 2017

issue

3

1 reference

10 September 2017

page(s)

817-823

1 reference

Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2054-0

The equilibrative nucleoside transporter family, SLC29

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2054-0

Molecular identification of the equilibrative NBMPR-sensitive (es) nucleoside transporter and demonstration of an equilibrative NBMPR-insensitive (ei) transport activity in human erythroleukemia (K562) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2054-0

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2054-0

Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2054-0

Mammalian nucleoside transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2054-0

Tumor dihydropyrimidine dehydrogenase expression is a useful marker in adjuvant therapy with oral fluoropyrimidines after curative resection of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2054-0

Imatinib inhibition of fludarabine uptake in T-lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2054-0

Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2054-0

Nucleobase transport by human equilibrative nucleoside transporter 1 (hENT1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2054-0

Gene expression in colorectal cancer and in vitro chemosensitivity to 5-fluorouracil: a study of 88 surgical specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2054-0

10.1007/S00280-012-2054-0

21 January 2018

Identifiers

DOI

1 reference

release_ygkgdkh6b5f4hbg45aotu7i5ei

10 September 2017

Fatcat ID

0 references

1 reference